close 73% no Admiral Markets UK Ltd. privātajiem ieguldītājiem savos kontos zaudē naudu, veicot CFD tirdzniecību. Ieguldījumi ir saistīti ar riskiem, un tie var nebūt piemēroti visiem investoriem. CFD ir pietiekami sarežģīti instrumenti, un tiem ir augsts risks attiecībā uz strauju naudas zaudēšanu sviras finansējuma dēļ. 73% no Admiral Markets UK Ltd. privātajiem ieguldītājiem savos kontos zaudē naudu, veicot CFD tirdzniecību. Jums būtu jāapsver tas, vai izprotat, kā CFD darbojas, un vai jūs varat atļauties uzņemties augsto naudas zaudēšanas risku.
Change languageLatviešu
Treidera Kabinets
Home・Akciju saraksts・Vivesto AB
Search

Vivesto AB

Slēgts

0.22

Cenas atjauninājums 2025. g. 29. okt. 12:20 UTC

PirktPārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.22

Max

0.22

Galvenie mērījumi

By Trading Economics

Ienākumi

-1.2M

-9.5M

EPS

-0.018

Darbinieki

4

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 11. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-7.3M

122M

Iepriekšējā atvēršanas cena

0.22

Iepriekšējā slēgšanas cena

0.22

Vivesto AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 7. nov. 21:06 UTC

Galvenie tirgus virzītāji

JBS Down After Trump Calls for Probe into Meat-Packing Companies

DJ

Lasīt

2025. g. 7. nov. 22:36 UTC

Peļņas

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

DJ

Lasīt

2025. g. 7. nov. 22:22 UTC

Peļņas

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

DJ

Lasīt

2025. g. 7. nov. 22:03 UTC

Peļņas

Constellation Software 3Q Rev $2.95B >CSU.T

DJ

Lasīt

2025. g. 7. nov. 22:03 UTC

Peļņas

Constellation Software 3Q Net $210M >CSU.T

DJ

Lasīt

2025. g. 7. nov. 22:03 UTC

Peļņas

Constellation Software 3Q EPS $9.89 >CSU.T

DJ

Lasīt

2025. g. 7. nov. 21:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

DJ

Lasīt

2025. g. 7. nov. 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

DJ

Lasīt

2025. g. 7. nov. 20:59 UTC

Peļņas

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

DJ

Lasīt

2025. g. 7. nov. 20:26 UTC

Tirgus saruna

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 20:22 UTC

Peļņas

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

DJ

Lasīt

2025. g. 7. nov. 20:04 UTC

Tirgus saruna

Oil Futures Close Choppy Week With Losses -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 19:34 UTC

Tirgus saruna

Gold Posts Small Gain for Week -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 19:31 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 19:17 UTC

Peļņas

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

DJ

Lasīt

2025. g. 7. nov. 19:09 UTC

Peļņas

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

DJ

Lasīt

2025. g. 7. nov. 19:08 UTC

Peļņas

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

DJ

Lasīt

2025. g. 7. nov. 18:31 UTC

Tirgus saruna

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 17:27 UTC

Tirgus saruna

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

DJ

Lasīt

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

DJ

Lasīt

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

DJ

Lasīt

2025. g. 7. nov. 17:17 UTC

Iegādes, apvienošanās, pārņemšana

Satair Expects to Complete Purchase in Early 2026

DJ

Lasīt

2025. g. 7. nov. 17:17 UTC

Iegādes, apvienošanās, pārņemšana

Satair: Deal Includes Unical's and ecube's Seven Operational Sites and Offices, With Combined 2024 Rev of $298M and Headcount of 413

DJ

Lasīt

2025. g. 7. nov. 17:15 UTC

Iegādes, apvienošanās, pārņemšana

Airbus Unit Satair to Buy Unical Aviation From Platinum Equity

DJ

Lasīt

2025. g. 7. nov. 17:09 UTC

Tirgus saruna

PENN Is Falling Further Behind Competitors -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 16:49 UTC

Tirgus saruna

Losing ESPN Partnership Will Hurt PENN -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 16:24 UTC

Tirgus saruna

OPEC+'s Output Hike Pause Comes Amid Excess Supply, Lower Spare Capacity -- Market Talk

DJ

Lasīt

2025. g. 7. nov. 16:17 UTC

Tirgus saruna

Oil Market Faces Oversupply But "Glut" Might Be Overblown -- Market Talk

DJ

Lasīt

Vivesto AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
help-icon Live chat